Summary - VRTX - NASDAQ - Weiss Ratings

C

Vertex Pharmaceuticals Incorporated VRTX

$511.74 $8.541.70%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$377.85 - $519.88

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Biotechnology Health Care Pharmaceutical

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

--

Headlines

MaxCyte: Building the Future of Cell and Gene Therapy Innovation

1/23/2025 - MarketBeat

Trade Tracker: Steve Weiss buys Vertex Pharmaceuticals

3/24/2025 - CNBC Television-YouTube

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now

3/24/2025 - Insider Monkey

Vanguard Group Inc. Acquires 98,654 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/24/2025 - MarketBeat

Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/24/2025 - MarketBeat

Simplify Asset Management Inc. Acquires Shares of 4,689 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/24/2025 - MarketBeat

Promising Biotech Stocks To Keep An Eye On - March 22nd

3/23/2025 - MarketBeat

Jim Cramer on Vertex (VRTX): "A Revolutionary Anti-Pain Drug"

3/23/2025 - Insider Monkey

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Virtu Financial LLC

3/23/2025 - MarketBeat

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Washington Trust Bank

3/23/2025 - MarketBeat

TD Private Client Wealth LLC Sells 7,470 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/23/2025 - MarketBeat

2 Beaten-Down Stocks to Buy on the Dip

3/22/2025 - Fool.com Headlines

Biotech Stocks To Follow Today - March 21st

3/22/2025 - MarketBeat

Cyrus J. Lawrence LLC Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/22/2025 - Ticker Report

TD Private Client Wealth LLC Sells 7,470 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/22/2025 - Ticker Report

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 1,428 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/22/2025 - MarketBeat

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Vinva Investment Management Ltd

3/22/2025 - MarketBeat

OVERSEA CHINESE BANKING Corp Ltd Acquires Shares of 1,233 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/22/2025 - MarketBeat

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

3/21/2025 - Zacks Investment Research

Market Pullback After a Historic Rally: What Investors Should Do Now

3/21/2025 - Zacks Investment Research

Insider Sell: David Altshuler Sells Shares of Vertex Pharmaceuticals Inc (VRTX)

3/21/2025 - GuruFocus

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?

3/21/2025 - Zacks Investment Research

Northwest & Ethical Investments L.P. Has $11.20 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/21/2025 - MarketBeat

Maryland State Retirement & Pension System Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

3/21/2025 - MarketBeat

Vertex's Pain Drug: Big Pharma's Next Major Success?

1/16/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Thursday, February 13, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Week of May 5 and 9 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Dec 19, 2024 - $377.85

52-week High

Nov 08, 2024 - $519.88

Valuation

Market Cap

$129.22B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

617 341 6100

Address

50 Northern Avenue
Boston, MA 02210

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF... more